Summit Therapeutics Inc. (SMMT) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Summit Therapeutics Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.779 And thank you for joining us. Two press releases were issued earlier this morning and 00:00:04.779 -- 00:00:08.045 are available on the homepage of our website. 00:00:08.045 -- 00:00:13.634 Our Form 10-K was also filed earlier this morning and is available on our website. 00:00:13.634 -- 00:00:18.502 Today's call is being simultaneously webcast and an archived replay will also be made 00:00:18.502 -- 00:00:23.227 available later today on our website, www.smmtx.com. 00:00:27.014 -- 00:00:30.699 Joining me on the call today is Bob Duggan, our Chairman of the Board and Chief Executive 00:00:30.699 -- 00:00:35.885 Officer, Dr. Mekshbi Zangade, our Chief Executive Officer and President, Manmeet 00:00:35.885 -- 00:00:39.750 Soni, our Chief Operating Officer and Chief Financial Officer, and Dr. 00:00:39.750 -- 00:00:43.432 Alan Yang, our Chief Medical Officer. 00:00:43.895 -- 00:00:47.620 Before we get started with the rest of the call, I would like to note that some statements 00:00:47.620 -- 00:00:52.746 made by our management team and some responses to questions that we may make today may 00:00:52.746 -- 00:00:56.663 be considered forward-looking statements based on our current expectations. 00:00:56.663 -- 00:01:01.309 Summit cautions that these forward-looking statements are subject to risks and uncertainties 00:01:01.309 -- 00:01:06.115 that may cause actual results to differ materially from those indicated in the forward-looking 00:01:06.115 -- 00:01:11.862 statements. Please refer to our SEC filings for information about these risks and uncertainties. 00:01:11.862 -- 00:01:15.747 Summit undertakes no obligation to update these forward-looking statements except as 00:01:15.747 -- 00:01:18.010 required by law. 00:01:18.010 -- 00:01:...